0001144204-17-035813.txt : 20170705
0001144204-17-035813.hdr.sgml : 20170705
20170705210205
ACCESSION NUMBER: 0001144204-17-035813
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170703
FILED AS OF DATE: 20170705
DATE AS OF CHANGE: 20170705
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001270073
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223868459
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 450 W. 15TH STREET
STREET 2: SUITE 505
CITY: NEW YORK
STATE: NY
ZIP: 10011
BUSINESS PHONE: 646-747-1000
MAIL ADDRESS:
STREET 1: 450 W. 15TH STREET
STREET 2: SUITE 505
CITY: New York
STATE: NY
ZIP: 10011
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kapadia Sandip
CENTRAL INDEX KEY: 0001677141
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35668
FILM NUMBER: 17950688
MAIL ADDRESS:
STREET 1: 450 WEST 15 STREET
STREET 2: SUITE 505
CITY: NEW YORK
STATE: NY
ZIP: 10011
4
1
v470324_form4.xml
FORM 4
X0306
4
2017-07-03
0
0001270073
INTERCEPT PHARMACEUTICALS INC
ICPT
0001677141
Kapadia Sandip
C/O INTERCEPT PHARMACEUTICALS, INC.
10 HUDSON YARDS, FLOOR 37
NEW YORK
NY
10001
0
1
0
0
Chief Financial Officer
Common Stock
2017-07-03
4
S
0
1431
121.5927
D
20569
D
Each employee of the Issuer who has received restricted stock awards has agreed to a mandatory sale of a sufficient number of shares of common stock to cover his or her withholding tax amounts upon the vesting of such restricted stock awards. The sales denoted here were made pursuant to such agreement to cover withholding tax obligations of the employee.
/s/ Bryan Yoon, as attorney-in-fact
2017-07-05